Takeda Pharmaceutical Company Stocks List Ranked

Takeda Pharmaceutical Company ETFs
Recent Takeda Pharmaceutical Company News

Symbol	Grade	Name	% Change
CRDF	D	Cardiff Oncology, Inc.	-1.99
AMGN	A	Amgen Inc.	-1.77
ALNY	D	Alnylam Pharmaceuticals, Inc.	-0.44
GOSS	F	Gossamer Bio, Inc.	-0.01
RXRX	F	Recursion Pharmaceuticals, Inc.	0.00
XOMA	C	XOMA Corporation	0.00
OVID	F	Ovid Therapeutics Inc.	0.00
TAK	F	Takeda Pharmaceutical Company Limited	0.00
STTK	B	Shattuck Labs, Inc.	0.00
ITCI	C	Intra-Cellular Therapies Inc.	0.73

View As Page of Charts

Related ETFs - A few ETFs which own one or more of the above listed Takeda Pharmaceutical Company stocks.

Symbol	Grade	Name	Weight
BBH	B	Market Vectors Biotech ETF	16.98
IBBQ	C	Invesco Nasdaq Biotechnology ETF	11.58
IBB	C	iShares Nasdaq Biotechnology Index Fund	11.39
FBT	D	First Trust Amex Biotech Index Fund	10.53
BIS	D	ProShares UltraShort Nasdaq Biotechnology	9.95

View all Takeda Pharmaceutical Company ETFs...

Compare ETFs

Compare BBH to FBT Compare IBB to FBT Compare IBBQ to FBT

Takeda Pharmaceutical Company Stocks Recent News

Date	Stock	Title
May 6	AMGN	Investors Pile Into Amgen in Search of Next Obesity Drug Payout
May 5	AMGN	Cathie Wood's Ark Invest Snaps Up $3.54M Worth Of Shares In This Biopharma Company Following Positive Obesity Pipeline Update
May 5	ALNY	The Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) First-Quarter Results Are Out And Analysts Have Published New Forecasts
May 4	AMGN	Amgen First Quarter 2024 Earnings: EPS Misses Expectations
May 4	AMGN	Amgen Could Become A Real Contender In The Obesity Market
May 4	AMGN	Decoding Amgen Inc (AMGN): A Strategic SWOT Insight
May 3	AMGN	Why Amgen Stock Zoomed Nearly 12% Higher Today
May 3	RXRX	Recursion Pharmaceuticals (RXRX) Increases Yet Falls Behind Market: What Investors Need to Know
May 3	AMGN	Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
May 3	AMGN	Analyst unveils Amgen stock price target after weight-loss drug data
May 3	AMGN	Amgen's Q1 Earnings: Solid All Court Progress, Major Weight Loss Catalyst Pending
May 3	ALNY	Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript
May 3	AMGN	Interest rate cuts could switch ‘from stroll to a sprint’ after US jobs surprise
May 3	AMGN	William Blair, Barclays upgrade Amgen following GLP-1 drug update
May 3	ALNY	Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y
May 3	AMGN	Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition
May 3	AMGN	US STOCKS-Wall St rallies after soft jobs data allays rate jitters
May 3	AMGN	Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
May 3	AMGN	Weight-loss drug competition heats up. Is Wegovy in trouble?
May 3	AMGN	Amgen Inc. (NASDAQ:AMGN) Q1 2024 Earnings Call Transcript

Takeda Pharmaceutical Company: The Takeda Pharmaceutical Company Limited (武田薬品工業株式会社, Takeda Yakuhin Kōgyō kabushiki gaisha) [takeꜜda jakɯçiŋ koꜜːɡʲoː] is a Japanese multinational pharmaceutical and biopharmaceutical company. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 49,578 employees worldwide and achieved US $19.299 billion in revenue during the 2018 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo.
In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

More about Takeda Pharmaceutical Company

Browse All Tags